MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.xcrm.2025.102302

Медицинская библиотека · Cell reports. Medicine · 2025

Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety.

Barish Michael E, Aftabizadeh Maryam, Hibbard Jonathan, Blanchard M Suzette, Ostberg Julie R, Wagner Jamie R, Manchanda Mishika, Paul Jinny, Stiller Tracy, Aguilar Brenda, Starr Renate, Arvanitis Leonidas, Ressler Julie A, Kilpatrick Julie, Kong Yuthana, Wang Dongrui, Forman Stephen J, D'Apuzzo Massimo, Brown Christine E, Badie Behnam

СтатьяКлиническое исследование I фазыПеревод в очереди

Аннотация

A challenge in treating glioblastoma (GBM) is its phenotypic heterogeneity between patients and within tumors. Chlorotoxin (CLTX), a peptide from scorpion venom, broadly binds glioma cells through a mechanism involving surface matrix metalloproteinase-2 (MMP-2). We previously developed chimeric antigen receptor (CAR) T cells incorporating CLTX as the GBM recognition domain. Here, we report interim clinical experience of a phase 1 trial evaluating intracavity/intratumoral (ICT) delivery of CLTX-CAR T cells in four patients with MMP-2-expressing recurrent GBM (NCT04214392), with the primary objectives of feasibility and safety. The therapy is well tolerated with no dose-limiting toxicities. Three of the four participants (75%) exhibit a best response of stable disease. CLTX-CAR T cells are detected in the tumor cavity fluid and at lower levels in the blood. Human anti-CAR antibody assays do not detect humoral immunogenicity against the CLTX-CAR. These observations support further clinical evaluation of CLTX-CAR therapy.

Для цитирования: Barish Michael E, Aftabizadeh Maryam, Hibbard Jonathan, Blanchard M Suzette, Ostberg Julie R, Wagner Jamie R, Manchanda Mishika, Paul Jinny, Stiller Tracy, Aguilar Brenda, Starr Renate, Arvanitis Leonidas, Ressler Julie A, Kilpatrick Julie, Kong Yuthana, Wang Dongrui, Forman Stephen J, D'Apuzzo Massimo, Brown Christine E, Badie Behnam. Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety.. Cell reports. Medicine. 2025. DOI: 10.1016/j.xcrm.2025.102302.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.